Over our nearly two decades of operation, Synteract has become a full-service contract research organization with a proven track record of success supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Company employees and management have a unique understanding of the financial and time challenges faced by small to mid-sized biopharmaceutical companies in day to day business operations, and have developed the systems and processes to guide them in drug and medical device discovery and development.
This is the way we do business, a promised standard that includes ongoing support from a specialized team dedicated to meeting or exceeding your expectations. With our “Shared Work –Shared Vision” philosophy, Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients can get to decision points faster. We have been a trusted outsourcing partner to clients for many years, and are proud to have supported 22 product approvals in our first 17 years of operation. Synteract delivers trials internationally and offers expertise across therapeutic areas including a notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology.
Every project matters, and each project is unique. We know that and tailor our approach for each and every one. Our mission is to provide high quality yet personal service, working closely with drug and device sponsors as though we were a department within your company. Our full-service capabilities allow us to handle an entire program or the services specifically needed by our clients, from protocol strategy to regulatory submission and post-marketing.
Over our 17 year history, we have saved many studies; in fact, we rescued 24 studies in 2010 through early 2012 alone. More than 90% of our business comes to us from repeat business and direct referrals from customers because of our customer-focused philosophy and support.
We offer flexible technological solutions to support the effective management of your trials. Our experienced teams support multiple industry recognized software and technology platforms to deliver our services. SynCapture, our hybrid EDC platform, allows multiple modes of data entry in one study including web based, paper and fax to make data capture easy at a low cost.
Our low turnover in personnel and high experience levels mean you are working with specialized teams familiar with our processes, and aware of our dedication to quality and customer delivery. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract currently employs over 350 experienced professionals in our three offices and regionally throughout the U.S.
Perhaps our most important differentiator of all, we deliver what we promise. We are accessible – any time, any level, anyone. Synteract offers you direct access to our executive, senior management and project teams. Transparency in projects is a critical component to our partnership.
Additionally, we have partnered with key international firms in order to provide outstanding patient cost and time-to-enrollment advantages in regions such as Eastern and Western Europe, Australia, India, and Brazil. Synteract endeavors to be your global outsourcing firm as we continue to build a solid platform for quality international trials.
Our promised
standard ensures a
customized approach,
responsive service
and timely results.
Send us your RFP
to learn more.